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rnal of Stroke and CerIntroduction: If health professionals are to involve major stroke patients and their
families in making decisions about treatments, they need to describe prognosis in
terms that are easily understood. We suggest that referring to “specific abilities”,
such as ability to be independent, walk, talk, eat normally, be continent, live with-
out severe pain, live without major anxiety or depression and to live at home may
be more easily understood than terms such as disabled based on the modified Ran-
kin scale (mRs). Objective: We aimed to describe the “specific abilities” and quality
of life of patients in each mRs level at six months after major stroke. Patients and
methods: A longitudinal cohort study of patients admitted to hospital with major
stroke with follow up at six months. Results: We recruited 403 patients, mean age
77.5yrs. The number (%) in each mRs level at six months was 0 (no problems): 8
(2%), 1: 45(11.2%), 2: 7(1.7%), 3: 149(37.1%), 4: 46(11.4%), 5: 36(9.0%) and 6(dead)
111(27.6%). Patients within each mRs level varied with respect to their “specific
abilities” and quality of life. For example, of the 36(9%) patients with mRs 5, 30
(83%) could talk, 14(39%) were continent, 33(92%) were not in severe pain, 22(61%)
did not have major anxiety/depression and 5(14%) could live at home. Their
median utility (derived from HRQoL) was -0.08 (range -0.35 to 0.43). Discussion and
Conclusions: Describing prognosis with the mRs does not convey the variation in
specific abilities and HRQoL amongst patients with major stroke. Therefore,
describing prognosis in terms of “specific abilities”may be more appropriate.
Key Words: Major strok—Specific abilities—Prognosis—Communication
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under
the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)Introduction
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where an early treatment decision to accept or decline
treatments may influence outcomes.2 For example, accept-
ing treatments such as intermittent pneumatic compres-
sion3 and early tube feeding4 increase the likelihood that
the patient will survive, but be left with significant disabil-
ity whereas declining these treatments may result in ear-
lier death. However, terms such as ‘disability’ may have
varied meanings to different people. Similarly, where
health related quality of life (HRQoL) is reported, this is
expressed as utilities (i.e. the desirability of a health out-
come between -1 (worse health state) to 1 (excellent health
state)) derived from the EQ5D or similar scales.5 How-
ever, this may not be easily communicated. Furthermore,
different individuals would have different perceptions of
their HRQoL.
Although the deficits and needs of stroke survivors
with respect to their mobility, communication and psy-
chological well-being has been reported,6 treatment104993 1
2 A. VISVANATHAN ET AL.decisions early on after a major stroke are often made
based on predictions of death or severe disability.7 This
is because disability scales such as the modified Rankin
scale (mRs) which has seven levels ranging from 0 (No
problems) to 6 (Dead)8 and the Barthel Index (BI), a func-
tional scale describing the ability of patients to perform
several different activities of daily living are familiar to
health professionals.9 Furthermore, there are statistical
models which have been validated for use in research to
predict death and disability.10 In contrast, there is con-
siderable uncertainty with respect to the recovery of
patients’ specific abilities (e.g. mobility, speech) and a
lack of adequately validated statistical models to predict
these abilities.11
An important step in involving patients and families in
decision-making is for health professionals to be able to
effectively communicate information on patient prognosis
in terms that are easily understood and on which they
might base their decisions.
We hypothesised that patients and their families
might find it more helpful if we described patients’
prognosis in terms of “specific abilities”;2 i.e. ability to
be independent, to walk, to talk, to eat normally, to be
continent, to live without severe pain, to live without
major anxiety or depression and to live at home.
Patients admitted with major stroke described seeking
hope, so expressing outcomes in positive terms (abili-
ties), rather than negative ones (disabilities) may be
more appropriate.12 A first step towards communicat-
ing prognosis effectively was to describe the “specific
abilities” and HRQoL of patients six months after major
stroke and to relate these to their mRs.Table 1. Definitions of “specific abilities” after stroke based on dich
question
Specific abilities at
six months
Measure Able
To be independent smRsq 0-2
To walk smRsq Able
To talk* Specific question** No dysphasia, Mild
dysphasia
To eat normally Specific question** Normal or Oral mod
To be continent BI Continent or occasio
To live without severe
pain
EQ5D 5L No pain, mild or mo
discomfort
To live without major
anxiety or depression
EQ5D 5L Not anxious/ depres
moderately anxiou
To live at home Specific question** Own home or famili
*language assessment only.
**options given and dichotomised.Materials and Methods
We adhered to the STROBE (Strengthening the Report-
ing of Observational Studies in Epidemiology) guidelines
for cohort studies.13
We prospectively recruited a longitudinal cohort of adults
(>18 years) within 10 days of a major stroke in a UK teach-
ing hospital and followed them up at about six months. Eli-
gible patients had mRs 3-5 (described as a ‘poor’ outcome in
clinical trials)14 or mRs 0-2 (a ‘good’ outcome) but a defi-
ciency due to the stroke with respect to at least two specific
abilities. Patients or proxies (where the patient lacked capac-
ity) provided written informed consent.
At baseline and at six months, we determined patients’
mRs using the simplified modified Rankin scale question-
naire (smRsq),15 their BI (scored 0-100)8 and HRQoL with
the EQ5D-5L.5 We derived utilities using the published
crosswalk calculator.16 Proxies completed assessments
where patients were unable to do so. We derived “specific
abilities” based on single items from these commonly
used and validated scales or for abilities which were not
addressed by these scales i.e. eating, talking and living at
home, by asking a specific question. For example, we
derived ‘able to be continent’ from answers provided to
urine and bowel continence items on BI and ‘able to eat
normally’ by asking patients/ families the patients’ ability
to eat food at six months (i.e. normal diet, oral modified
diet, nasogastric feed, feed through percutaneous endo-
scopic gastrostomy or radiologically inserted gastro-
stomy). We dichotomised each “specific ability” into
‘able’ or ‘unable’ based on judgements of stroke professio-
nals at the recruiting hospital. (Table 1).
The Scotland A Research Ethics Committee (Ref: 17/SS/
0029) approved our protocol. We used Stata 15 (Timber-
lake, 2017) for analyses.otomies on single items from smRsq, BI, EQ5D-5L, or specific
s.
Unable
3-5
Unable
or Moderate Severe dysphasia, Mute
ified Nasogastric tube, Percutaneous gastro-
stomy or Radiologically inserted
gastrostomy
nal accidents Incontinent/catheterised
derate pain or Severe or extreme pain or discomfort
sed, slightly or
s/ depressed
Severely or extremely anxious/
depressed
es home Residential home, Care home or
Hospital
“SPECIFIC ABILITIES” AFTER MAJOR STROKE 3Results
We recruited 403 patients between 10th May 2017 and
25th May 2018. Their mean age was 77.5 (SD 11.7) and
209/403 (52%) had a baseline mRs of five. (Table 2)
At six months the number and percentage of patients in
each mRs level was 0 (no problems): 8(2%), 1: 45(11.2%), 2: 7
(1.7%), 3: 149(37.1%), 4: 46(11.4%), 5: 36(9.0%) and 6 (dead)
111(27.6%). Few (60/402, 15%) had a ‘good’ outcome, i.e.
mRs 0-2. One patient was uncontactable. (Table 3)
Patients within each mRs level, especially mRs 3, 4 and
5, varied with respect to their “specific abilities” and
HRQoL (Table 3). For example, of the 36 (9%) patients
with mRs 5, 30(83%) could talk, 14(39%) were continent,
33 (92%) were not in severe pain, 22(61%) did not have
major anxiety/depression and 5(14%) could live at home.
Their median utility was -0.08 but ranged from -0.35 to
0.43. Of the 45 (11.2%) patients with mRs 1, all were able
to talk, eat normally, be continent, not have major anxi-
ety/depression and live at home, but two patients (4%)
were in severe pain. Their median utility was 0.84 but
ranged from 0.32 to 1.Table 2. Baseline characteristics of cohort
Variable Categories Total n=403 %
Age (years) mean
(Standard Deviation
(SD))
77.5 (11.7)
Gender Male 179 44.4
Female 224 55.6
Independent before
stroke*
308 76.4
Living alone before
stroke*
158 39.2
Pre-existing dementia 49 12.2
Atrial fibrillation Current
Past
47
89
11.7
22.1
Previous stroke or
transient ischaemic
attack
123 30.5
Stroke Subtype Haemorrhagic
Ischaemic
63
340
15.6
84.4
Able to lift arms after
stroke*
152 37.8
Able to walk after
stroke*
28 6.9
Able to talk* 248 61.5
Baseline mRs 0
1
2
3
4
5
0
2
4
17
171
209
0
0.5
1
4.2
42.4
51.9
Baseline Barthel Index
(BI) Mean (SD)
31.5 (25.6)
Baseline Utility Mean
(SD)
0.23 (0.36)
*Six Simple variable.Discussion/Conclusion
In this cohort of patients with major stroke, few had a
‘good’ outcome based on their mRs (mRs 0-2) at six
months. There was considerable variation in “specific
abilities” and HRQoL within each mRs level, especially
amongst those with mRs 3-5 at six months after major
stroke. Therefore, by describing patients’ “specific abili-
ties,” health professionals may be able to give patients
and their families a fuller picture of what the patients’
future life might look like. This may allow better discus-
sion of patient preferences and involvement in making
treatment decisions.
Several previous attempts have been made to relate
physical disability to HRQoL by assigning utility scores to
mRs levels.17,18 Our findings broadly agree with their
findings; i.e. patients with higher mRs tended to have
lower utilities. However, we have also shown that utilities
varied, with a wide range within each mRs level.
Studies have reported that patients and their caregivers
(often family members) require psychological support after
major stroke6,19 and have also described how the psycholog-
ical support needs of caregivers of patients who are physi-
cally dependent after stroke may differ.20 Our findings add
to this; for instance, the knowledge that a proportion of
physically disabled patients may also suffer frommajor anx-
iety and depression may allow health professionals to assess
these patients and deliver early tailored information to them
and their family members. This may include information on
relevant support services for both patients and their families
e.g. counselling and neuropsychology.21
Strengths and limitations
We have successfully recruited and followed up patients
with major stroke who are often excluded from research
studies. Our cohort was of modest size (n=403), were
recruited prospectively and with minimal loss to follow up.
However, based on our inclusion criteria of major
stroke patients, some mRs levels at six months included
only small numbers of patients. Therefore, estimates
based on these groups may be imprecise. We also
recruited patients from a single centre only which may
reduce the generalisability of our results. HRQoL assess-
ments were completed by proxies where the patient was
unable to do so. Therefore, for some “specific abilities”
which were derived from EQ5D-5L (e.g. to live without
severe pain and to live without major anxiety/depres-
sion), it is impossible to know if the answers provided by
proxies were the same as the patients would have
provided.2224 Utilities are also derived from assessments
completed by healthy (non-disabled) individuals rather
than those who are disabled. However, in the absence of
alternative methods to obtain patients’ assessments of
their HRQoL (where patients lacked capacity) and deriv-
ing utilities, it is difficult to know how these could be
improved.
Table 3. Specific abilities and utilities in each mRs level at six months, n=4 2
mRs at about six months after stroke
0 1 2 3 4 6 All
Number (%) 8(2.0) 45(11.2) 7(1.7) 149(37.1) 46(11.4) 6(9.0) 111(27.6) 402(100)
Mean utility (Standard
Deviation)
0.90(0.09) 0.82(0.14) 0.78(0.12) 0.37(0.37) 0.20(0.19) 0.08(0.15) 0 0.50 (0.36)
Median Utility (total
range)
0.88
(0.74 to 1)
0.84
(0.32 to 1)
0.84
(0.61 to 0.91)
0.32
(-0.01 to 1)
0.21
(-0.26 to 0.72)
0.08
-0.35 to 0.43)
0 0.62 (-0.35 to 1)
Specific abilities: n (% in
mRs category)
Live independently
(smRsq)
8(100) 45(100) 7(100) 0 0 0 60(15)
Walk (smRsq) 8(100) 45(100) 7(100) 149(100) 0 0 209(52)
Talk 8(100) 45(100) 7(100) 137(92) 43(93) 0(83) 0 270(67)
Eat normally 8(100) 45(100) 7(100) 149(100) 45(98) 3(92) 0 287(71)
Be continent (BI) 8(100) 45(100) 7(100) 147(99) 38(83) 4(39) 0 259(64)
Live without major
anxiety or depression
(EQ5D-5L)
8(100) 45(100) 6(86) 132(89) 37(80) 2(61) 0 250(62)
Live without severe pain
(EQ5D-5L)
8 (100) 43 (96) 7(100) 143 (96) 41 (89) 3 (92) 0 275(68)
Live at home 8(100) 45(100) 7(100) 137(92) 17(37) (14) 0 219 (54)
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“SPECIFIC ABILITIES” AFTER MAJOR STROKE 5We collected data on “specific abilities” judged to be use-
ful to patients and their family members by stroke doctors
in the hospital where recruitment took place. We
acknowledge that different individuals may have differ-
ent opinions on “specific abilities” that may be useful and
how these should be defined.
Some specific abilities could have been derived from sev-
eral measures in our cohort. For instance, ‘to walk’ could
have been derived from three measures: a) smRsq specific
question: ‘Can you walk from one room to another without
the aid from another person?’ b) Single item from BI:
Mobility on a level surface or c) Dimension from EQ5D-5L:
Mobility. We used the smRsq as our primary measure to
define ‘to walk’ as we felt that there was less ambiguity in
defining ‘able’ and ‘unable’ based on ‘yes’ or ‘no’ to the
specific question. This is in contrast to BI and EQ5D which
have several levels or dimensions respectively and we
would need to decide a cut-off to define ‘able’ and ‘unable’.
As shown in Supplementary tables 1 and 2, each measure
would categorise different numbers of patients as being
‘able’ or ‘unable’ to walk. Varying our cut-offs for ‘able’
and ‘unable’would also change our results.
A useful next step would be to obtain feedback from
patients and families on how they wish prognosis to be
communicated to them in the context of a major stroke.
Beyond that, we could develop statistical models to pre-
dict patients’ “specific abilities”. These might allow clini-
cians to provide more formal predictions of patients
having a “specific ability” in the future and guide shared
decision-making regarding treatments after major stroke.Conclusions
We have shown that describing prognosis based on
mRs does not convey the variation in “specific abilities”
and HRQoL amongst patients with major stroke. There-
fore, describing patients’ “specific abilities” may be more
appropriate. This may help patients and families prepare
for the potential impact of major stroke and also to be
involved in making treatment decisions.Acknowledgement
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